Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $73.12 USD
Change Today +1.25 / 1.74%
Volume 6.5M
LLY On Other Exchanges
Symbol
Exchange
New York
Mexico
SIX Swiss Ex
Sao Paulo
EN Paris
Frankfurt
As of 8:04 PM 05/1/15 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - ELI LILLY & CO (LLY)

Eli Lilly and Company to Report Q3, 2015 on Oct 22, 2015
CapIQ 10/22/2015 1:00 PM ET
Eli Lilly and Company to Report Q1, 2015 on Apr 23, 2015
CapIQ 10/22/2015 1:00 PM ET
Eli Lilly and Company to Report Q4, 2014 on Jan 30, 2015
CapIQ 10/22/2015 1:00 PM ET

2013 revenues at Eli Lilly and Company totaled $23.1B USD, while annual earnings equaled $4.15 per share.

Quarterly Earnings & Estimates - ELI LILLY & CO (LLY)

Actuals vs. Estimates for ELI LILLY & CO LLY

Eli Lilly and Company's Quarterly Earnings

Eli Lilly and Company reported 2nd quarter 2014 earnings of $0.68 per share on 07/26/2014.

Annual Earnings & Estimates - ELI LILLY & CO (LLY)

Actuals vs. Estimates for ELI LILLY & CO LLY

Eli Lilly and Company's Annual Earnings

Eli Lilly and Company reported annual 2013 earnings of $4.15 per share on 02/1/2014.

Quarterly Revenues - ELI LILLY & CO (LLY)

Actuals vs. Estimates for ELI LILLY & CO LLY

Eli Lilly and Company's Quarterly Revenues

Eli Lilly and Company had 2nd quarter 2014 revenues of $4.9B USD. This bettered the $4.9B USD consensus of the 12 analysts covering the company. This was -16.8% below the prior year's 2nd quarter results.

Annual Revenues - ELI LILLY & CO (LLY)

Actuals vs. Estimates for ELI LILLY & CO LLY

Eli Lilly and Company's Annual Revenues

Eli Lilly and Company had revenues for the full year 2013 of $23.1B USD. This was 2.3% above the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LLY:US $73.12 USD +1.25

LLY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AbbVie Inc $64.32 USD -0.34
AstraZeneca PLC 4,462 GBp -35.00
Bristol-Myers Squibb Co $64.66 USD +0.93
Medtronic PLC $75.60 USD +1.15
Teva Pharmaceutical Industries Ltd $62.17 USD +1.75
View Industry Companies
 

Industry Analysis

LLY

Industry Average

Valuation LLY Industry Range
Price/Earnings 35.8x
Price/Sales 4.0x
Price/Book 5.0x
Price/Cash Flow 37.1x
TEV/Sales 3.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ELI LILLY & CO, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.